PA
Profund Advisors Portfolio holdings
AUM
$2.78B
1-Year Return
29.53%
This Quarter Return
+12%
1 Year Return
+29.53%
3 Year Return
+153.44%
5 Year Return
+262.59%
10 Year Return
+738.89%
AUM
$1.94B
AUM Growth
+$146M
(+8.1%)
Cap. Flow
-$2.11M
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,030
New
86
Increased
382
Reduced
498
Closed
64
Top Buys
| 1 |
Linde
LIN
|
+$4.14M |
| 2 |
Match Group
MTCH
|
+$4.09M |
| 3 |
Zoom
ZM
|
+$3.69M |
| 4 |
COUP
Coupa Software Incorporated
COUP
|
+$3.09M |
| 5 |
Amazon
AMZN
|
+$2.29M |
Top Sells
| 1 |
AbbVie
ABBV
|
+$5.56M |
| 2 |
Apple
AAPL
|
+$4.76M |
| 3 |
Amgen
AMGN
|
+$4.2M |
| 4 |
Gilead Sciences
GILD
|
+$2.62M |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.32M |
Sector Composition
| 1 | Technology | 31.77% |
| 2 | Healthcare | 17.92% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Communication Services | 12.74% |
| 5 | Financials | 5.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Liberty Global Class C
LBTYK
$4.01B
| $722K | 0.04% |
35,147
-917
| -3% | -$18.8K |
|
352
Morgan Stanley
MS
$242B
| $722K | 0.04% |
14,933
-851
| -5% | -$41.1K |
|
|
PPD
353
DELISTED
PPD, Inc. Common Stock
PPD
| $722K | 0.04% |
19,529
+5,622
| +40% | +$208K |
|
354
Moody's
MCO
$90.5B
| $720K | 0.04% |
2,485
-277
| -10% | -$80.3K |
|
355
Fomento Económico Mexicano
FMX
$30.1B
| $718K | 0.04% |
12,778
+717
| +6% | +$40.3K |
|
356
KB Financial Group
KB
$29B
| $717K | 0.04% |
22,310
+1,783
| +9% | +$57.3K |
|
357
Marathon Petroleum
MPC
$55.8B
| $717K | 0.04% |
24,439
-3,198
| -12% | -$93.8K |
|
358
Global Payments
GPN
$21B
| $716K | 0.04% |
4,033
-7
| -0.2% | -$1.24K |
|
359
Centene
CNC
$14.9B
| $705K | 0.04% |
12,094
-2,947
| -20% | -$172K |
|
360
Rio Tinto
RIO
$101B
| $702K | 0.04% |
11,621
-2,923
| -20% | -$177K |
|
361
Toro Company
TTC
$7.71B
| $701K | 0.04% |
8,348
+3,422
| +69% | +$287K |
|
362
FibroGen
FGEN
$46.1M
| $697K | 0.04% |
678
-88
| -11% | -$90.5K |
|
363
Ambev
ABEV
$34.6B
| $696K | 0.04% |
308,050
+17,252
| +6% | +$39K |
|
364
AstraZeneca
AZN
$251B
| $696K | 0.04% |
12,693
-3,601
| -22% | -$197K |
|
|
LHCG
365
DELISTED
LHC Group LLC
LHCG
| $696K | 0.04% |
3,276
+1,535
| +88% | +$326K |
|
366
Nektar Therapeutics
NKTR
$885M
| $695K | 0.04% |
2,791
-307
| -10% | -$76.4K |
|
367
Sanofi
SNY
$115B
| $690K | 0.04% |
13,746
-2,548
| -16% | -$128K |
|
368
HCA Healthcare
HCA
$96.9B
| $686K | 0.04% |
5,504
-1,335
| -20% | -$166K |
|
369
Aon
AON
$79.4B
| $684K | 0.04% |
3,315
-303
| -8% | -$62.5K |
|
370
Viatris
VTRS
$12.1B
| $682K | 0.04% |
45,967
-5,746
| -11% | -$85.3K |
|
371
RenaissanceRe
RNR
$11.2B
| $680K | 0.04% |
4,006
+1,615
| +68% | +$274K |
|
|
AMED
372
DELISTED
Amedisys
AMED
| $665K | 0.03% |
2,812
+859
| +44% | +$203K |
|
373
Huazhu Hotels Group
HTHT
$11.3B
| $665K | 0.03% |
15,375
+1,325
| +9% | +$57.3K |
|
|
BLUE
374
DELISTED
bluebird bio
BLUE
| $664K | 0.03% |
950
-158
| -14% | -$110K |
|
375
Valero Energy
VLO
$50.2B
| $663K | 0.03% |
15,315
-2,013
| -12% | -$87.1K |
|